Web Content Management
PRODUCTS
-
The semi-automated capsule filler is part of the Explore Range, offering the potential to simplify formulation by eliminating the need for additional ‘formulation for powder filling’ steps.
-
Revolutionizing Global mRNA Production: Germfree's Innovative Cleanrooms Drive Manufacturing Success
Cleanroom requirements for mRNA manufacturing encompass stringent particle control, temperature and humidity management, solvent management and robust contamination prevention strategies. Germfree’s advanced cleanroom solutions address these challenges, ensuring seamless equipment integration, process adaptability, and compliance with regulatory standards. Their tailored mobile and modular facilities support the emerging trend for localized vaccine production, empowering biopharmaceutical companies to harness the transformative potential of mRNA technology in a rapidly advancing field, and ultimately contributing to global immunization efforts.
-
By removing barriers, and bringing trials to patients where they live, we can expand the geographical reach of clinical research across the globe allowing more patients to participate. Our patient-centric delivery means we can create convenience and comfort working the schedule of the trial around the schedule of the patient and their family, not the other way around. This approach provides important access to medical care, enhances the inclusivity of clinical trials and advances drug development for all.
-
Navigating the technical challenges of mAbs production and scalability
Monoclonal antibodies (mAbs) offer promising immunotherapy treatments, targeting antigens and diseases. Manufacturing these complex therapies presents challenges in scaling up, cost, and consistency. Germfree’s expertise in tailored cleanroom solutions addresses these obstacles, ensuring sterility and seamless equipment integration. By providing advanced facilities for both small-scale clinical trials and larger-scale production, Germfree contributes to the successful development and commercialization of mAbs, ultimately improving patient outcomes and transforming healthcare landscapes.
-
Enables secure real-time document review, co-authoring, and redaction in order to shorten the document review process by up to 65%.
WHITE PAPERS AND CASE STUDIES
-
Fulfilling MDR Requirements For A Groundbreaking Microsurgery Robot
Discover the help a company pioneering the field of open surgery received to advance their robotic technology, replacing their former EDC system to improve their clinical research efficiency.
-
Mobilizing Compliance: USP 797 And 800 Pharmacy Trailer Fleet For VA Hospitals
VA hospitals across the US are undergoing renovations to bring their facilities into compliance. The challenge was to design and manufacture a fleet of self-sufficient mobile compounding pharmacies.
-
Meet The Demand: Doubling Capacity At Two 503(b) Manufacturing Sites
503B compounders require special attention to maintain cGMP and regulation compliance. Examine the process for designing and managing new facilities for sterile and parenteral injectable manufacturing.
-
Accelerating Cold Chain Expansion: Responding To COVID-19 Challenges
Review how leveraging cross-functional teamwork helped complete a cold chain infrastructure expansion in a fraction of the expected timeline, ensuring the production of essential COVID-19 therapeutics.
-
Revolutionizing Wastewater Management In Four Cities Through Water Mixing
Historically, lift station operators have turned to chemical treatments as the primary means of managing grease buildup. However, these methods carry inherent drawbacks.
-
Fresenius Kabi Relies On Analyzer From Swan
A global healthcare company specializing in lifesaving medicines and technologies was looking for online TOC measurement for its production site. Discover which analyzer the site chose and why.
-
Bridging The Gap During Organizational Restructuring For Continuity
Navigating workforce turnover and restructuring can threaten project timelines. Discover how leveraging an experienced on-site team can ensure long-term continuity.
-
Enhancing Phase 1 Clinical Trials With Point-Of-Need Safety Assessments
A Mobile Clinical Suite (MCS) proved to be the solution that Syneos Health needed to resolve their Phase 1 study trial challenges with comprehensive eye exams.
-
Building A High-Quality IND From Scratch With Strategic Gap Analysis
A biotech sponsor lacking in-house regulatory expertise engaged a partner to obtain strategic regulatory review, medical writing, project management, and electronic publishing (eCTD).
-
Case Study: Connexin Is Taking The UK's 'Smart Cities' To The Next Level
With Skedulo, Connexin is streamlining processes via automation, increasing connectedness between their office & field teams, and elevating their customer experience.
-
Spotlight On India: Regulatory Enhancements, Modernization, And Robust Data Collection
Explore India's adoption of global best practices, 24/7 work cycles, and audit readiness to ensure high standards of Good Clinical Practice, attract more trials, and provide robust data to stakeholders.
-
Accelerating Approval Pathway For Phase III Ovarian Cancer Trial
A late-stage biotech developing a first-in-class therapy for a rare, chemo-resistant form of ovarian cancer sought help for accelerated FDA approval.
NEWS
-
Computational Approach Yields Novel Cancer Targets9/5/2024
Researchers at Weill Cornell Medicine have used artificial intelligence to identify drug targets based on mapping regulatory networks in patient tumors.
-
Elumina Health Announces The Launch Of New AI Capability In BasisEHR—The First AI-Powered EHR For Post-Acute Home Healthcare4/15/2025
Elumina Health Inc announces the launch of AI based patient risk triaging capability in Basis EHR. Basis EHR leverages AI to identify home healthcare patients who are at high risk for hospitalization on the basis of their demographic and medical data.
-
GE Healthcare And Medis Medical Imaging Announce Collaboration Focused On Non-Invasive Coronary Assessments To Help Advance Precision Care In Treatment Of Coronary Artery Disease5/14/2024
Today, GE HealthCare, a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, and Medis Medical Imaging, a leading cardiac imaging software company, announced their collaboration aimed at helping advance precision care in the diagnosis and treatment of coronary artery disease (CAD).
-
Applied DNA Receives Approval For TR8(TM) Pharmacogenomic (PGx) Testing Service From New York State Department Of Health6/13/2024
Applied DNA Sciences, Inc. ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that the New York State Department of Health ("NYSDOH") approved the Company's TR8 PGx ("TR8") pharmacogenomic (PGx) testing service.
-
New Cancer Drug Boosts Effectiveness Of Chemotherapy – Even In Resistant Tumours8/11/2025
A groundbreaking cancer drug could enhance how patients respond to chemotherapy even in treatment-resistant tumours.